Dataset Information

Global phosphotyrosine survey reveals activation of multiple tyrosine kinase signaling pathways in triple negative breast cancer

ABSTRACT: About 15-20% of all breast cancers are triple negative breast cancers, which are often highly aggressive. We performed global quantitative phosphotyrosine profiling of a large panel of triple negative breast cancer cell lines using high resolution Fourier transform mass spectrometry. Our study identified 1,903 tyrosine-phosphorylated peptides derived from 969 proteins. Heterogeneous activation of tyrosine kinases was observed in triple negative breast cancer derived cell lines.

INSTRUMENT(S): LTQ Orbitrap Velos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Akhilesh Pandey

LAB HEAD: Akhilesh Pandey

PROVIDER: PXD001222 | Pride | 2016-07-06

REPOSITORIES: pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 55

Publications

Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways.

Wu Xinyan X Zahari Muhammad Saddiq MS Ma Binyun B Liu Ren R Renuse Santosh S Sahasrabuddhe Nandini A NA Chen Lily L Chaerkady Raghothama R Kim Min-Sik MS Zhong Jun J Jelinek Christine C Barbhuiya Mustafa A MA Leal-Rojas Pamela P Yang Yi Y Kashyap Manoj Kumar MK Kashyap Manoj Kumar MK Marimuthu Arivusudar A Ling Min M Fackler Mary Jo MJ Merino Vanessa V Zhang Zhen Z Zahnow Cynthia A CA Gabrielson Edward E Stearns Vered V Roa Juan Carlos JC Sukumar Saraswati S Gill Parkash S PS Pandey Akhilesh A

Oncotarget 20151001 30

Breast cancer is the most prevalent cancer in women worldwide. About 15-20% of all breast cancers are triple negative breast cancer (TNBC) and are often highly aggressive when compared to other subtypes of breast cancers. To better characterize the biology that underlies the TNBC phenotype, we profiled the phosphotyrosine proteome of a panel of twenty-six TNBC cell lines using quantitative high resolution Fourier transform mass spectrometry. A heterogeneous pattern of tyrosine kinase activation ...[more]

PMID: 26356563

			Action	DRS
	BT20.msf	Msf
	BT20.raw	Raw
	BT549.msf	Msf
	BT549.raw	Raw
	HBL100.msf	Msf

Dataset Information

Global phosphotyrosine survey reveals activation of multiple tyrosine kinase signaling pathways in triple negative breast cancer

Dataset's files

Publications

Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

A common cell state in Triple Negative Breast Cancers can be targeted through inhibition of Spleen Tyrosine Kinase (SYK)
2016-06-15 | PXD001680 | Pride

Shin_2018_EGFR-PYK2-c-Met interaction network_model
2024-09-02 | BIOMD0000000826 | BioModels

Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan
2012-02-02 | GSE33095 | GEO

Comparative proteomic profiling of secreted extracellular vesicles from breast fibroadenoma and malignant lesion patients: a pilot study
2022-05-31 | PXD027197 | Pride

Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan
2012-02-02 | E-GEOD-33095 | biostudies-arrayexpress

Differential analysis of nucleolar proteomics in triple negative breast cancer
2021-03-05 | PXD021201 | Pride

FZD7 Plays a Critical Role in Triple Negative Breast Cancer Proliferation
2011-06-01 | E-GEOD-27447 | biostudies-arrayexpress

FOXC1 in triple negative breast cancer
| PRJNA882754 | ENA